February 25, 2021
Business News

Lineage to Present at the Raymond James 42nd Annual Institutional Investors Conference on March 1, 2021 and the H.C. Wainwright Global Life Sciences Conference on March 9, 2021


CARLSBAD, Calif.–()–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, Chief Executive Officer, will be presenting at the Raymond James 42nd Annual Institutional Investors conference on March 1, 2021 at 11:40am Eastern Time / 8:40am Pacific Time. Mr. Culley will also be presenting at the H.C. Wainwright Global Life Sciences Conference, being held virtually March 9-10, 2021.

Interested investors can access the live and archived webcasts on the Events and Presentations section of Lineage’s website. Additional videos are available on the Media page of the Lineage…



Click here to view the original article.

Related Posts

You might also like ...

AON Splash Image
Wellington Management Expands Private Investing Capabilities with New Climate-Focused Senior Investors
Genus plc Reports Interim First Half 2021 Fiscal Year Results
L&T Technology Services Selected by Airbus for Skywise Partner Programme